Shanghai, China

Xiaojuan Zhang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations and Contributions of Inventor Xiaojuan Zhang

Introduction

Xiaojuan Zhang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative patents. With a total of 3 patents, her work focuses on developing novel therapeutic agents.

Latest Patents

Xiaojuan Zhang's latest patents include a JAK kinase inhibitor and a preparation method for the same, along with applications in the field of medicine. This innovative small molecule JAK inhibitor is designed to provide improved efficacy and safety in preventing or treating JAK-related indications. Additionally, she has developed a vortioxetine pamoic acid salt and its crystal form, which enhances the residence time of vortioxetine in vivo, achieving a slow release suitable for long-acting dosage forms.

Career Highlights

Throughout her career, Xiaojuan Zhang has worked with notable companies such as Shanghai Synergy Pharmaceutical Sciences Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to contribute to the advancement of pharmaceutical sciences.

Collaborations

Xiaojuan Zhang has collaborated with talented individuals in her field, including her coworkers Yunfei Li and Xiaoer Xia. These collaborations have further enriched her research and development efforts.

Conclusion

Xiaojuan Zhang's innovative work in medicinal chemistry and her contributions through her patents highlight her role as a significant inventor in the pharmaceutical industry. Her advancements in JAK inhibitors and vortioxetine formulations demonstrate her commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…